Another risky one but with a new income stream things are looking up for Sun.
Why they did not perform better last year is anyones guess.
I suppose the big boys have been let down before but this time its different .
Take a look - long term holder.....

Surgical Innovations Group plc

("SI" or "the Group")

Appointments to the Clinical Advisory Board

Surgical Innovations Group plc (AIM:SUN), the designer and manufacturer of innovative medical devices, is pleased to announce the appointment of arthroscopic specialist Mr Jon Conroy and laparoscopic specialist Mr Marco Adamo to its Clinical Advisory Board (CAB) with immediate effect.

Mr Jon Conroy, BSc, MB ChB, FRCS (Eng), FRCS (Tr & Orth), MSc, is a Consultant Orthopaedic Surgeon specialising in joint replacements and arthropscopic, or 'keyhole', surgeries to the hip and knee. Mr Conroy is a member of the British Hip Society, International Society of Hip Arthroscopy, The British Orthopaedic Association and a Fellow of The Royal College of Surgeons of England. He also holds a master's degree in Mechanical Engineering from Leeds University. Mr Conroy has published research in several medical journals and won the GlaxoSmithKlein Orthopaedic Essay Prize in 2005 and the John Fitton Prize for Orthopaedic Specialist Registrars in 2006.

Mr Marco Adamo, MD is a Consultant Surgeon and Bariatric Surgery Lead at the University College London Hospital (UCLH) where he has worked since 2007. He graduated in 1995 with full marks and honours in Palermo, Italy where he also completed his training in general surgery. Since moving to the UK in 2000 he has focused on advanced laparoscopic surgery and laparoscopic bariatric (obesity) surgery. He performed the first single incision laparoscopic sleeve gastrectomy in the UK and also has a specific interest in laparoscopic hernia surgery. As a dedicated trainer in his field he often runs advanced training courses for UK and European surgeons. Mr Adamo is a member of the European Association of Endoscopic Surgery (EAES), British Society for Metabolic and Obesity Surgery (BOMSS), Association of Upper-GI Surgeons (AUGIS) and Association of Laparoscopic Surgeons in UK (ALS) and Italy (SICE).

Graham Bowland, Chief Executive Officer for Surgical Innovations, said: "We are very pleased to welcome Jon and Marco to the CAB. Jon's expertise in arthroscopy will be invaluable as we begin to develop minimally invasive surgical devices for this very important market. Marco's appointment will strengthen our specialist bariatric team and significantly add value to the development of devices for this particular area of surgery. Our CAB now consists of nine highly experienced surgeons covering a wide range of specialism and markets."

SUN having another run on reasonable volume.

Up on reasonable volume (for SUN).

Final Results

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative medical devices, is pleased to announce its final results for the 12 months ending 31 December 2010.

Financial highlights

-- Revenue increased 55% to GBP7.045 million (2009: GBP4.541 million)

-- Pre-tax profit increased 487% to GBP1.549 million (2009: GBP264,000)

-- Operating margins increased to 22% (2009: 6%)

-- Net cash of GBP2.2 million generated from operating activities

-- Basic earnings per share of 0.48p (2009: 0.14p)

Operational highlights

-- Own brand sales increased 30% to GBP3.852 million (2009: GBP2.956 million); driven by flagship Resposable(R) products

-- OEM revenues increased 71% to GBP2.506 million (2009: GBP1.463 million)

-- Industrial sales boosted by delivery of GBP616,000 order

-- Continued major investment in research and development, plant and manufacturing

Doug Liversidge, Chairman of the Group, said: "The Group has undergone yet another year of transformation, successfully meeting the demands of rapid growth. We have continued to invest heavily in the business while R&D capability has undergone a step-change to speed up new product development and improvements to our existing technology. This has proven to be very appealing to potential OEM customers and as a result we are seeing an influx of enquires for a range of minimally invasive devices. With an already promising start to 2011, we are looking forward with confidence."

Very muted response - oh well, I'll just have to wait another ten years or so.

1 in 10 years!

I have had it for 20 years now!!!! I don't know where is the paper though!

Ten year high today.

Nice chart!

Somewhat different to the 20 year!

Ever so slightly!!!

SUN is shining again today.

Yes - an excellent candle!

And that will be 10p!

The sky's the limit, if you see what I mean?!

RNS Number : 4848F

Surgical Innovations Group PLC

26 April 2011

SURGICAL INNOVATIONS GROUP PLC

DIRECTOR / PDMR SHAREHOLDING

Surgical Innovations Group plc (the "Company") announces that it has received notification that Mr D B Liversidge CBE, Non-Executive Chairman of the Company, on 21(st) April 2011 transferred 1,000,000 ordinary shares of 1p each into Quest Investments Ltd a company owned by him and Mrs Pamela Liversidge, OBE. Following this transaction Mr. Liversidge's beneficial interest in the Company remains unchanged at 6,171,821 ordinary shares representing 1.57 per cent. of the issued share capital.

I am removing ALL my research from here due to the constant personal abuse, defamation and distortions of it posted by:

ptholden

hlyeo98

halifax

blackdown

kimoldfield

cynic


This bunch of abusive retards is the reason MoneyAM will NEVER have a forum worth reading.

I have reported them to support by they do nothing, either because they want to force me to PAY them for the Traders Room or because they are too lazy to do anything. Maybe the people in support are the ones perpetrating the abuse, so as to force people to pay for the premium boards. Either way the service is sh1te and a disgrace to the finance industry. No wonder there is nobody left here apart from morons.

I will continue posting my good research on boards that are run in accordance with FSA and LSE listing rules and the interests of the market, not here where ar5eh0les rule the boards and all decent research is buried under their piles of sh1te.

Issue of Equity.

Close above 10p - AGM on the 20th.

Another tick up here today.